Axsome Therapeutics, Inc.
(NASDAQ : AXSM)

( )
AXSM PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
0.00%17.512.0%$143.77m
JAZZJazz Pharmaceuticals Plc
0.23%136.922.3%$116.03m
ICPTIntercept Pharmaceuticals, Inc.
-0.46%109.3418.6%$97.75m
SAGESAGE Therapeutics, Inc.
1.35%158.848.8%$92.54m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-2.26%165.026.3%$89.59m
HZNPHorizon Pharma plc
0.11%26.877.3%$84.75m
PRGOPerrigo Co. Plc
-0.97%46.796.8%$65.55m
ICLRICON Plc
0.56%133.624.1%$57.47m
UTHRUnited Therapeutics Corporation
-0.42%120.2914.3%$56.84m
MNKMallinckrodt Plc
-2.22%21.6021.0%$51.07m
PTLAPortola Pharmaceuticals, Inc.
0.31%32.077.6%$41.99m
AERIAerie Pharmaceuticals, Inc.
-2.80%45.516.9%$37.81m
ENDPEndo International Plc
-0.84%8.268.9%$37.51m
MYOKMyoKardia, Inc.
-4.49%51.872.4%$34.79m
MDCOMedicines Company
0.68%26.7621.8%$30.83m

Company Profile

Axsome Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies for the management of central nervous system disorders. Its product candidates include AXS-02 and AXS-06 which are developing for multiple indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.